Assembly Bill 775 aims to establish a cost-sharing cap for epinephrine delivery systems under health insurance policies and self-insured governmental health plans in Wisconsin. The bill stipulates that these policies cannot impose cost-sharing amounts exceeding $60 for two doses of any medically necessary epinephrine delivery system, which is defined as a device approved by the FDA that administers a premeasured dose of epinephrine to treat life-threatening allergic reactions. The bill amends existing statutes to include this new provision, specifically creating section 632.895 (12r) to outline the coverage requirements and limitations.

Additionally, the bill clarifies that while insurers may not exceed the $60 cap, they are permitted to impose lower cost-sharing amounts if they choose. The legislation also includes provisions regarding its applicability to existing policies, particularly those affected by collective bargaining agreements, ensuring that the new requirements take effect in alignment with the terms of such agreements. The bill is set to take effect four months after its publication.

Statutes affected:
Bill Text: 609.83